期刊文献+

急性脑梗死患者血清脂蛋白相关性磷脂酶A2水平的变化及意义 被引量:12

Change of serum level of lipoprotein associated phospholipase A2 and its significance in patients with acute cerebral infarction
下载PDF
导出
摘要 目的探讨血清脂蛋白相关性磷脂酶A2(Lp-PLA2)含量与急性脑梗死患者脑损伤程度的相关性。方法对比32例急性脑梗死患者与20例健康者血清Lp-PLA2含量,并根据神经功能缺失评分及梗死面积分别将急性脑梗死患者分为轻度神经损伤、中度神经损伤和重度神经损伤3个亚组和小面积梗死、中面积梗死及大面积梗死3个亚组。分析血清LpPLA2含量与神经功能缺失程度及梗死面积的相关性。结果急性脑梗死组血清Lp-PLA2含量明显高于健康组(P<0.05)。且经单因素方差分析,神经损伤程度亚组和梗死面积亚组,组间血清Lp-PLA2含量差异有统计学意义(P<0.05),且均存在显著相关性(P<0.05)。结论急性脑梗死患者血清Lp-PLA2水平明显升高,可用于评估患者的神经损伤程度和梗死面积。 Objective To explore the correlation between serum lipoprotein associated phospholipase A2 (Lp-PLA2) con- tent and the brain damage in patients with acute cerebral infarction. Methods Serum Lp-PLA2 content of 32 cases of patients with acute cerebral infarction and 20 cases of healthy person were compared, and according to the neural function defect score and infarct size patients with acute cerebral infarction were divided into mild, moderate and severe neurological damage sub- groups and into small , moderate and large area of infarction subgroup. The correlation between serum Lp-PLA2 content and degree of nerve function loss and infarction area were analyzed. Results In patients with acute cerebral infarction group serum Lp-PLA2 in patients was significantly higher than in healthy group (P 〈0.05). And by the single factor analysis of variance, serum Lp-PLA2 content had significant difference between each subgroups (P〈0.05), and there were significant correlation (P〈0.05). Conclusion Serum level of Lp-PLA2 in acute cerebral infarction patients increase significantly, and can be used to assess degree of patients neurological damage and the infarction area.
作者 许光
出处 《中国实用神经疾病杂志》 2013年第21期20-21,共2页 Chinese Journal of Practical Nervous Diseases
关键词 急性脑梗死 LP-PLA2 相关性 Acute cerebral infarction Lp-PLA2 Correlation
  • 相关文献

参考文献5

二级参考文献39

  • 1周晓辉,贺春钰.颈动脉粥样硬化对冠状动脉病变的预测分析[J].中国动脉硬化杂志,2005,13(2):218-220. 被引量:34
  • 2刘甲兴,郑兴,秦永文,丁继军,赵仙先,曹江.脂蛋白相关性磷脂酶A_2活性能反映冠状动脉粥样硬化病变程度[J].第二军医大学学报,2006,27(4):391-395. 被引量:31
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 4Stafforini DM, Tjoelker LW, McCormick SP, et al. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem, 1999, 274:7018-7024.
  • 5Zalewski A, Macphee CH. Role of lipoprotein-associated phospholipase A2 in atherosclerosis : biology, epidemiology, and possible therapeutic. Arterioscler Thromb Vase Biol, 2005, 25 : 923 -931.
  • 6Macphee CH, Nelson J, Zalewski A. Role of lipoproteinassociated phospholipase A2. in atherosclerosis and its potential as a therapeutic target. Currt Opin Pharmacol,2006, 6 : 154-161.
  • 7O' Donoghue M, Morrow DA, Sabatine MS, et al. Lipoproteinassociated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 ( PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation, 2006, 113: 1745-1752.
  • 8Tsimihodimos V, Karabina SA, Tambaki AP, et al. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type Ⅱ A and type Ⅱ B. Arterioscler Thromb Vasc Biol, 2002, 22: 306-311.
  • 9Kot sis VT, Pitiriga VCh, Stabouli SV, et al. Carotid artery intima-media t hickness could predict the preaence of coronary artery lesions [ J]. Am J Hypertens, 2005, 18 (5Pt1) : 601-606.
  • 10Hansson G. Inflammation, athercsclerosis, and coronary artery disease [J]. N Engl J Med , 2005 , 352 :1685-695.

共引文献337

同被引文献101

  • 1府伟灵,徐克前.临床生物化学检验[M].第5版.北京:人民卫生出版社,2012.1:15.
  • 2中华医学会神经科分会.各类脑血管病诊断要点[J].中华神经科杂志,1996,29(6):279-280.
  • 3Biselli PM,Guerconi AR,de Godoy MF? et al .Genetic poly-morphisms involved in folate metabolism and concentrationsof methylmalonic acid and folate on plasma homocysteine andrisk of coronary artery disease [J]. J Thromb Thrombol,2010,29(1):32-40.
  • 4Ryabinkina Y V,Gnedovskaya E V,Maksimova M Y,et al.Stroke:incidence and risk factors for venous thromboembolic complications in intensive care unit[J].Anesteziol Reanimato,2015,60(5):54-59.
  • 5Nagele E P,Demarshall C,Freeman T,et al.Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition:beneficial effects of the Lp PLA2inhibitor darapladib[J].J Alzheimers Dis,2013,35(1):179-198.
  • 6Palmerini T, Biondi -Zoccai G, Della Riva D, et al. Stent throm- bosis with drug - eluting and bare - metal stents : evidence from a comprehensive network meta- analysis [ J ]. Lancet, 2012, 379 (9824) : 1393 - 1402.
  • 7Air - Oufella H, Mallat Z, Tedgui A. Lp - PLA2 and sPLA2 : car- diovascular biomarkers [ J]. Med Sei ( Paris), 2014, 30 ( 5 ) : 526 - 531.
  • 8Dullaart RP, van Pelt LJ, Kwakernaak AJ, et al. Plasma lipopro- rein- associated phospholipase A2 mass is elevated in STEMI com- pared to non - STEM/ patients but does not discriminate between myocardial infarction and non -cardiac chest pain[ J]. Clin Chim Acta, 2013, 424(9) : 136- 140.
  • 9Tellis CC, Moutzouri E, Elisaf M, et al. The elevation of apoB in hypereholesterolemic patients is primarily attributed to the relative increase of apoB/Lp - PLA2 [ J ]. J Lipid Res, 2013, 54 ( 12 ) : 3394 - 3402.
  • 10Marsche G. Lp -PLA2, Lp -PLA2, plaque inflammation and le- sion development vary fundamentally between different vascular sites [J]. JAmHeartAssoe, 2015, 4(2): 1-2.

引证文献12

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部